Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...

Detailed price information for Profound Medical Corp (PRN-T) from The Globe and Mail including charting and trades.

As a result, researchers have explored less invasive options that aim to treat the cancer while preserving quality of life. One such approach is TULSA, which uses real-time MRI guidance to deliver ...

The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy ...

A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

(MENAFN- GlobeNewsWire - Nasdaq) – First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to successfully recruit to ...

First Focal One ® procedure utilizing Cortechs.ai’s advanced MRI-imaging technology, OnQ Prostate, successfully performed at the University of California, San Francisco Prostate Cancer Center OnQ ...

Prostate cancer is the second-leading cause of cancer deaths in American men. Further, non-Hispanic Blacks have a higher incidence of prostate cancer and are more likely to die from it than are ...

For its 2nd anniversary, Callisto DataHub offers free annotated datasets of 50 suspected lung cancer X-rays and 50 ...

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...